6[6]Zhu QL,Qian XS,Wang SW,et al.A comparison of elderly and adult multiple organ dysfunction syndrome in the rat model.Exp Gerontol,2006,41:771-777.
7[8]Baue AE,Durham R,Faist E.Systemic inflammatory response syndrome(SIRS),multiple organ dysfunction syndrome(MODS),multiple organ failure (MOF):are we winning the battle?Shock,1998,10:79-89.
8[9]Tsutsumi-Ishii Y,Nagaoka I.Modulation of humandefensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production.J Immunol,2003,170:4226-4236.
9[10]Monick MM,Yarovinsky TO,Powers L,et al.Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.J Biol Chem,2003,278:53035-53044.
10[11]Farberman MM,Hoffmann JW,Ryerse JS,et al.Diffusible signal to murine alveolar maerophages from coli-stimulated lung type Ⅱ epithelial cells.Inflamm Res,2004,53:475-483.
5[2]Keh D. Immunocompetence in the critically ill: understanding the problem. Minerva Anestesiol, 2000,66: 358-361.
6[3]Paya M,Terencio MC,Ferrandiz ML,et al. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br J Pharmacol,1996,117: 1773-1779.
7[4]Shayevitz JR, Miller C, Johnson K J, et al. Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock, 1995,4:389-396.
8[5]Jansen ML Hendriks T, Verhofstad AA, et al. Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome. Shock,1997,8: 261-267.
9[9]Jackson R J, Johnson DD, Maxson RT, et al. A comparison of neonatal and adult multiorgan failure in a rat model. J Pediatr Surg, 2000,35: 428-431.
10[3]Nierman DM, Schechter CB, Cannon LM, et al. Outcome prediction mcdel for very elderly critically ill patients. Crit Care Med, 2001,29:1853-1859.
